Risk Factor for Superimposed Nosocomial Bloodstream Infections in Hospitalized Patients with COVID-19

References

• Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–402. doi:10.1002/jmv.25678
   PubMed Web of Science ®Google Scholar
• Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodriguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. doi:10.1016/j.cytogfr.2020.06.001
   PubMed Web of Science ®Google Scholar
• Group RC, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693–704.
   PubMed Web of Science ®Google Scholar
• Guimaraes PO, Quirk D, Furtado RH, et al. Tofacitinib in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;385(5):406–415. doi:10.1056/NEJMoa2101643
   PubMed Web of Science ®Google Scholar
• Rosas IO, Brau N, Waters M, et al. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N Engl J Med. 2021;384(16):1503–1516. doi:10.1056/NEJMoa2028700
   PubMed Web of Science ®Google Scholar
• Selvaraj V, Finn A, Lal A, Khan MS, Dapaah-Afriyie K, Carino GP. Baricitinib in hospitalised patients with COVID-19: a meta-analysis of randomised controlled trials. EClinicalMedicine. 2022;49:101489. doi:10.1016/j.eclinm.2022.101489
   PubMedGoogle Scholar
• McNamara JF, Righi E, Wright H, Hartel GF, Harris PNA, Paterson DL. Long-term morbidity and mortality following bloodstream infection: a systematic literature review. J Infect. 2018;77(1):1–8. doi:10.1016/j.jinf.2018.03.005
   PubMed Web of Science ®Google Scholar
• Santoro A, Franceschini E, Meschiari M, et al. Epidemiology and risk factors associated with mortality in consecutive patients with bacterial bloodstream Infection: impact of MDR and XDR bacteria. Open Forum Infect Dis. 2020;7(11):ofaa461. doi:10.1093/ofid/ofaa461
   PubMed Web of Science ®Google Scholar
• Garrouste-Orgeas M, Timsit JF, Tafflet M, et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis. 2006;42(8):1118–1126. doi:10.1086/500318
   PubMed Web of Science ®Google Scholar
• Tabah A, Koulenti D, Laupland K, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med. 2012;38(12):1930–1945. doi:10.1007/s00134-012-2695-9
   PubMed Web of Science ®Google Scholar
• Buetti N, Ruckly S, de Montmollin E, et al. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network. Intensive Care Med. 2021;47(2):180–187. doi:10.1007/s00134-021-06346-w
   PubMed Web of Science ®Google Scholar
• Osaki S, Kikuchi K, Moritoki Y, et al. Distinguishing coagulase-negative Staphylococcus bacteremia from contamination using blood-culture positive bottle detection pattern and time to positivity. J Infect Chemother. 2020;26(7):672–675. doi:10.1016/j.jiac.2020.02.004
   PubMed Web of Science ®Google Scholar
• Roberts FJ. Definition of polymicrobial bacteremia. Rev Infect Dis. 1989;11(6):1029–1030. doi:10.1093/clinids/11.6.1029
   PubMedGoogle Scholar
• Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. doi:10.1186/1710-1492-9-30
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829. doi:10.1097/00003246-198510000-00009
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Gupta RK, Harrison EM, Ho A, et al. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. 2021;9(4):349–359. doi:10.1016/S2213-2600(20)30559-2
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes Blood Pressure Work G. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1–S87. doi:10.1016/j.kint.2020.11.003
   PubMedGoogle Scholar
• Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med. 2006;34(10):2576–2582. doi:10.1097/01.CCM.0000239114.50519.0E
   PubMed Web of Science ®Google Scholar
• Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL. Severe bloodstream infections: a population-based assessment. Crit Care Med. 2004;32(4):992–997. doi:10.1097/01.CCM.0000119424.31648.1E
   PubMed Web of Science ®Google Scholar
• Mohus RM, Gustad LT, Furberg AS, et al. Explaining sex differences in risk of bloodstream infections using mediation analysis in the population-based HUNT study in Norway. Sci Rep. 2022;12(1):8436. doi:10.1038/s41598-022-12569-8
   PubMed Web of Science ®Google Scholar
• Giefing-Kroll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015;14(3):309–321. doi:10.1111/acel.12326
   PubMed Web of Science ®Google Scholar
• Ippolito M, Simone B, Filisina C, et al. Bloodstream infections in hospitalized patients with COVID-19: a systematic review and meta-analysis. Microorganisms. 2021;9(10):2016. doi:10.3390/microorganisms9102016
   PubMed Web of Science ®Google Scholar
• Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324(13):1307–1316. doi:10.1001/jama.2020.17021
   PubMed Web of Science ®Google Scholar
• Group CST, Munch MW, Myatra SN, et al. Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial. JAMA. 2021;326(18):1807–1817. doi:10.1001/jama.2021.18295
   PubMed Web of Science ®Google Scholar
• Kurt AF, Mete B, Urkmez S, et al. Incidence, risk factors, and prognosis of bloodstream infections in COVID-19 patients in intensive care: a single-center observational study. J Intensive Care Med. 2022;37(10):1353–1362. doi:10.1177/08850666221103495
   PubMed Web of Science ®Google Scholar
• Palanisamy N, Vihari N, Meena DS, et al. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study. BMC Infect Dis. 2021;21(1):933. doi:10.1186/s12879-021-06647-x
   PubMed Web of Science ®Google Scholar